POSEDEL RHEA J 4

What Happened
Rhea J. Posedel, a director of Aehr Test Systems (AEHR), received a grant of 1,895 restricted stock units (RSUs) on 2026-07-01. The filing reports an acquisition price of $0.00 for the award; these RSUs are compensation/award shares rather than an open-market purchase or sale.

Key Details

• Transaction date: 2026-07-01 (reported on Form 4 filed 2026-07-02).
• Transaction type/code: Award/Grant (A).
• Shares/units granted: 1,895 RSUs; reported price $0.00 (non-cash award).
• Shares owned after transaction: Not disclosed in the filing.
• Vesting/other notes: F1 — 1/4 of the total RSUs vest at the end of each three full calendar months following the grant date, provided the recipient remains a director. F2 — the reported amount includes shares subject to unvested RSUs.
• Timeliness: Filing appears timely (reported Date of Report 2026-07-01; filed 2026-07-02).

Context
RSU grants are a form of compensation subject to vesting and are not an immediate cash purchase or sale. Because these RSUs include unvested shares and vest over time if Posedel remains on the board, they do not represent an immediate market transaction and should be interpreted as a compensation award rather than a direct trading signal.